In the current study we evaluated the biological activities of a novel vimentin-targeting small molecule compound (R491) in cell lines of human lung, brain, gastric, liver, and pancreatic cancers, and investigated their underlying mechanisms. The gene discussed is VIM; the disease is familial pancreatic carcinoma.